Cacao

Raw cacao is one of the most flavanol-rich foods available. Unlike processed cocoa or milk chocolate, which lose the majority of their flavanol content through roasting, alkalization, and refining, raw or minimally processed cacao retains its full phytochemical profile. Cacao flavanols, primarily epicatechin and catechin oligomers (procyanidins), have been extensively studied for cardiovascular, metabolic, vascular, and cognitive benefits. The COSMOS trial, one of the largest dietary supplement RCTs ever conducted, confirmed a 27% reduction in cardiovascular mortality with cocoa extract supplementation, establishing cacao flavanols among the best-evidenced food-derived compounds for heart health.

Cardiovascular Protection {#cardiovascular-protection}

The COSMOS (COcoa Supplement and Multivitamin Outcomes Study) trial enrolled 21,442 US adults aged 60 years and older in a randomized, double-blind, placebo-controlled design over 3.6 years. Participants receiving 500 mg/day of cocoa flavanols (including 80 mg epicatechin) experienced a statistically significant 27% reduction in cardiovascular death compared to placebo. While the primary composite endpoint of total cardiovascular events did not reach significance in intention-to-treat analysis, per-protocol analyses of adherent participants showed reductions in total CVD events. A 2025 systematic review (PMC11992872) across multiple RCTs confirmed that flavanol interventions consistently improve peripheral and cerebral microvascular function, supporting a mechanistic basis for long-term cardiovascular protection.

Vascular Function {#vascular-function}

Cacao flavanols directly stimulate endothelial nitric oxide synthase (eNOS), increasing nitric oxide production in blood vessel walls. This causes vasodilation, reduces arterial stiffness, and improves flow-mediated dilation (FMD), a key measure of vascular health. A randomized trial found that two weeks of cocoa flavanol supplementation improved FMD in both young and elderly participants, and decreased pulse wave velocity, a marker of arterial stiffness. Critically, CF intake reversed age-related vascular burden in elderly participants, suggesting that regular cacao consumption may help offset the vascular aging that drives cardiovascular risk with age. Doses around 100 mg epicatechin have been identified as reliably improving FMD across studies.

Blood Pressure {#blood-pressure}

Multiple meta-analyses confirm blood pressure reductions with regular flavanol-rich cocoa intake. The effect is strongest in individuals with elevated baseline pressure. Cocoa flavanol doses of approximately 900 mg or above produce consistent reductions in systolic and diastolic blood pressure. The mechanisms include NO-mediated vasodilation, prostaglandin synthesis, and inhibition of vascular smooth muscle contraction. A meta-analysis of 31 RCTs (PMC5086796) found significant improvements in blood pressure among cocoa-consuming adults, with effects most pronounced in hypertensive or at-risk populations. A 2025 sub-analysis of the COSMOS trial found that while cocoa extract did not reduce overall hypertension incidence across all participants, those with normal baseline blood pressure showed a 30% reduced risk of developing hypertension, suggesting flavanols may act primarily as a preventive strategy against blood pressure elevation rather than a treatment for established hypertension.

Insulin Sensitivity {#insulin-sensitivity}

Cocoa flavanols significantly improve insulin sensitivity by activating AMPK signaling pathways and reducing oxidative stress in metabolic tissues. A systematic review and meta-analysis demonstrated that cocoa flavanol intake improved insulin sensitivity and lowered fasting insulin levels in adults. Observational studies associate regular dark chocolate consumption with reduced incidence of type 2 diabetes and metabolic syndrome. Flavonoids in cacao also modulate glucose homeostasis by inhibiting alpha-glucosidase activity, slowing carbohydrate absorption and reducing postprandial glucose spikes. These metabolic effects complement the cardiovascular benefits and suggest cacao flavanols act on multiple longevity-relevant pathways simultaneously.

Cognitive Health {#cognitive-health}

A 2014 randomized trial by researchers at Columbia University enrolled healthy adults aged 50 to 69 and assigned them to either a high-flavanol or low-flavanol cocoa diet for three months. Those in the high-flavanol group showed significantly improved memory performance and increased cerebral blood volume specifically in the dentate gyrus, a hippocampal subregion implicated in normal age-related memory decline. Some participants’ memory performance resembled that of people decades younger. The study provides the first direct evidence that dietary flavanols can reverse hippocampal dysfunction through improved blood flow to key memory circuits, not merely slow further deterioration.

Theobromine, a methylxanthine compound concentrated in cacao, may extend these benefits to the cellular aging level. A 2025 observational study in two European cohorts totaling 1,669 participants found that circulating theobromine levels were significantly associated with slower GrimAge epigenetic aging acceleration and longer telomere-length proxies, with results replicated across both cohorts. While causality has not been established, the finding raises the possibility that cacao’s full metabolite profile contributes to healthy aging beyond the flavanol-driven cardiovascular and vascular mechanisms.

Quality and caveats: Raw cacao and minimally processed dark chocolate (70%+ cacao) are the only reliable dietary sources of meaningful flavanol concentrations. Commercial milk chocolate contains little to no active flavanols. Cocoa powder intended for baking has typically been alkalized (dutched), which destroys most flavanols. Some commercial cacao powders may contain trace heavy metals; choosing reputable third-party tested brands reduces this risk. The Mars ACTICOA and CocoaVia processes specifically preserve flavanol content and were used in most clinical trials.